Alto Neuroscience Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Alto Neuroscience Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Mountain View
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: ANRO
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001999480
EIN: 83-4210124

Board of directors

Follow this board

Amit Etkin · Director · PRESIDENT AND CEO
Since 2024
Andrew Craig Miller · Director
Since 2026
Andrew Dreyfus · Director
Since 2024
Christopher Nixon Cox · Director
Since 2024
Gwill York · Director
Since 2024
Husseini Manji · Director
Since 2024
Maha Radhakrishnan · Director
Since 2024
Po Yu (Jeff) Chen · Director
Since 2024
Ramiro Sanchez · Director
Since 2025

Chief executives

Amit Etkin · PRESIDENT AND CEO

Since February 2024

Director election results

Annual meeting of May 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Gwill York

53.5%
Ramiro Sanchez

99.9%

Board connections

5 of this board's directors also sit on 7 other boards. 5 are in the same sector.

Shared director Other board Same sector

Candel Therapeutics Inc. Same sector
via Maha Radhakrishnan
Entrada Therapeutics Inc. Same sector
via Maha Radhakrishnan
High-Trend International Group
via Christopher Nixon Cox
Ironwood Pharmaceuticals Inc. Same sector
via Andrew Dreyfus
Kyverna Therapeutics Inc. Same sector
via Andrew Craig Miller
Newsmax Inc.
via Christopher Nixon Cox
Rapport Therapeutics Inc. Same sector
via Ramiro Sanchez

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $3,567,247; 3 sales by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Oct 2, 2026	Smith Nicholas Conrad Officer (PRESIDENT AND CFO)	Option exercise	+55,000	$2.32	$127,600
Sep 30, 2026	Smith Nicholas Conrad Officer (PRESIDENT AND CFO)	Option exercise	+24,056	$2.35	$56,532
Sep 30, 2026	Smith Nicholas Conrad Officer (PRESIDENT AND CFO)	Open-market sale	−23,170	$25.78	$597,290
Sep 30, 2026	Smith Nicholas Conrad Officer (PRESIDENT AND CFO)	Open-market sale	−886	$26.87	$23,807
Sep 29, 2026	Smith Nicholas Conrad Officer (PRESIDENT AND CFO)	Option exercise	+56,455	$2.35	$132,669
Sep 29, 2026	Smith Nicholas Conrad Officer (PRESIDENT AND CFO)	Option exercise	+54,375	$2.35	$127,781
Sep 29, 2026	Smith Nicholas Conrad Officer (PRESIDENT AND CFO)	Open-market sale	−110,830	$26.58	$2,946,150
May 14, 2026	Amit Etkin Director, Officer (PRESIDENT AND CEO)	Gift	−400,000	—	—
Mar 1, 2026	Amit Etkin Director, Officer (PRESIDENT AND CEO)	Shares withheld for tax	−6,227	$19.69	$122,610
Mar 1, 2026	Smith Nicholas Conrad Officer (CHIEF FINANCIAL OFFICER & CBO)	Shares withheld for tax	−2,806	$19.69	$55,250
Jul 10, 2024	Savitz Adam Officer (CHIEF MEDICAL OFFICER)	Open-market purchase	+2,931	$13.22	$38,748
Jul 9, 2024	Savitz Adam Officer (CHIEF MEDICAL OFFICER)	Open-market purchase	+10,681	$12.53	$133,833
Jul 9, 2024	Savitz Adam Officer (CHIEF MEDICAL OFFICER)	Open-market purchase	+1,388	$13.15	$18,252
Mar 28, 2024	Smith Nicholas Conrad Officer (CHIEF FINANCIAL OFFICER)	Open-market purchase	+1,600	$15.80	$25,280
Mar 28, 2024	Smith Nicholas Conrad Officer (CHIEF FINANCIAL OFFICER)	Open-market purchase	+4,550	$16.56	$75,348

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Alto Neuroscience Inc.

Who is the CEO of Alto Neuroscience Inc.?

Amit Etkin has been Alto Neuroscience Inc.'s PRESIDENT AND CEO since February 2024.

How many directors are on Alto Neuroscience Inc.'s board?

Alto Neuroscience Inc.'s board has 9 directors: Amit Etkin, Andrew Craig Miller, Andrew Dreyfus, Christopher Nixon Cox, Gwill York, Husseini Manji, Maha Radhakrishnan, Po Yu (Jeff) Chen and Ramiro Sanchez.

Are Alto Neuroscience Inc. insiders buying or selling shares?

Over the last 12 months, Alto Neuroscience Inc. insiders made no open-market purchases and sold $3.6 million of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Alto Neuroscience Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="alto-neuroscience-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.